Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Young Pharmacists : JYP|February 25, 2014
Development and validation of RP-HPLC method with ultraviolet detection for estimation of montelukast in rabbit plasma: Application to preclinical pharmacokineticsOm Prakash Ranjan, Usha Y Nayak, Meka Sreenivasa Reddy, et al.
Drug Development and Industrial Pharmacy|February 2, 2024
Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion: an in-vitro and ex-vivo investigationAthira R Nair, Sai Krishna Anand Vullendula, Dani Lakshman Yarlagadda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2019
Investigation of drug-polymer miscibility, biorelevant dissolution, and bioavailability improvement of Dolutegravir-polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer solid dispersionsDani Lakshman, Mohith Chegireddy, Geeta K Hanegave, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 28, 2014
Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with QuercetinSwapnil J Dengale, Syed Sajjad Hussen, B S M Krishna, et al.
AAPS Pharmscitech|November 8, 2020
Overview of Extensively Employed Polymeric Carriers in Solid Dispersion TechnologyAthira R Nair, Yarlagadda Dani Lakshman, Vullendula Sai Krishna Anand, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 12, 2023
In vitro, in-vivo, and in-silico investigation of physicochemical interactions between pioglitazone and rifampicinOmkar Londhe, Sayalee Sanjay Mane, Bhakti Umesh Hirlekar, et al.
Molecular Pharmaceutics|July 25, 2024
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability EnhancementDani Lakshman Yarlagadda, Subham Das, Sai Krishna Anand Vullendula, et al.
International Journal of Pharmaceutics|April 29, 2021
Considerations for the selection of co-formers in the preparation of co-amorphous formulationsDani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, Athira R Nair, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 27, 2018
The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materialsV Sai Krishna Anand, Sujata D Sakhare, K S Navya Sree, et al.
Pageof 3